Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0QR5G
|
|||
| Former ID |
DIB009853
|
|||
| Drug Name |
5-methoxypsoralen
|
|||
| Synonyms |
5-MOP
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Psoriasis vulgaris [ICD-11: EA90; ICD-9: 696] | Phase 3 | [1] | |
| Company |
Oclassen Pharmaceuticals Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H8O4
|
|||
| Canonical SMILES |
COC1=C2C=CC(=O)OC2=CC3=C1C=CO3
|
|||
| InChI |
1S/C12H8O4/c1-14-12-7-2-3-11(13)16-10(7)6-9-8(12)4-5-15-9/h2-6H,1H3
|
|||
| InChIKey |
BGEBZHIAGXMEMV-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 484-20-8
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:18293
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00533195) Comparison of UVA1 Phototherapy Versus Photochemotherapy for Patients With Severe Generalized Atopic Dermatitis. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.